Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. Vermij L, Jobsen JJ, Leon-Castillo A, Brinkhuis M, et al. Br J Cancer 2023 Jan 23. doi: 10.1038/s41416-023-02141.

Read + Share

Amedeo Smart

Independent Medical Education

Vermij L, Jobsen JJ, Leon-Castillo A, Brinkhuis M, et al. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. Br J Cancer 2023 Jan 23. doi: 10.1038/s41416-023-02141.
PMID: 36690721